©Shutterstock/David Smart New preclinical NIDA-funded research shows that a new compound, BU08028, acts on opioid and non-opioid brain receptors to relieve pain without harmful side effects. In the study, primates experienced pain relief but did not become dependent upon BU08028, and in fact,...
Photo by ©iStock.com/kitiara65/http://istockpho.to/1SWVugO A recent analysis of the 2015 Monitoring the Future (MTF) findings on e-cigarette use highlights uncertainty about what teens are actually inhaling when using "e-cig" devices, and at least six percent report they are using the vaporizers...
The National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) announced today that the next National Drug & Alcohol Facts WeekSM (NDAFW) will be held Jan. 23-29, 2017, with event registration beginning immediately. NDAFW is an annual, week-long...
©Shutterstock/vitstudio A new paper by the National Institute on Drug Abuse (NIDA) researchers suggests that a certain brain region—the amygdala central nucleus— plays a role in predicting reward value and allocating work accordingly. Rats expecting a reward show activation in this brain region,...
Pre-clinical research funded by the National Institute on Drug Abuse (NIDA) suggests that secondhand marijuana smoke may cause longer lasting cardiovascular harm than secondhand tobacco smoke. Image Courtesy of NIDA In this study, rats were exposed to secondhand marijuana or tobacco smoke at...
Teens who participate in daily sports and exercise activities are less likely to transition from opioid pain reliever use to heroin, according to research funded by the National Institute on Drug Abuse (NIDA), and published today in Pediatrics. There have been anecdotal reports of teen...
Courtesy of Braeburn Pharmaceuticals An editorial published today in The Journal of the American Medical Association by NIDA Director Dr. Nora Volkow and NIDA Deputy Director Dr. Wilson Compton discusses the importance of the new long-acting buprenorphine implant technology as an added tool in...
New research funded by the National Institute on Drug Abuse (NIDA) found that intensive patient navigation support and financial incentives used to motivate patients with substance use disorders to engage in their HIV care, had no beneficial effect on their HIV viral suppression rate. Even though...
Photo by ©Shutterstock.com/Pedro Bento A meta-analysis of smoking cessation therapies, funded by the National Institute on Drug Abuse (NIDA), showed that clinicians should strongly consider varenicline as the first treatment option for women who are trying to quit smoking. Varenicline, a...
©iStockphoto/megaflopp Research funded by the National Institute on Drug Abuse (NIDA) found that patients taking opioids for long-term chronic pain, who were given prescriptions for naloxone in a primary care setting, had 63 percent fewer opioid-related emergency department visits after one year...